Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

Confronted by rising global competition, regulatory bottlenecks, economic challenges, and other obstacles, bold new strategies are essential to accelerate biomedical innovation.

This resource explains low dose radiation therapy (LDRT) and what it does. It also explains what happens before LDRT, how to get ready, and what to expect after.

Research at MSK Our research impact Research topics Core facilities & resources ...

New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers why some leukemia patients stop responding to promising new drugs; examines how bone’s hardness shapes th ...

For people living with advanced triple-negative breast cancer (TNBC), a newly approved treatment may offer more time and a better quality of life. TNBC makes up about 10% to 20% of all breast cancers, ...

Memorial Sloan Kettering Cancer Center today announced that Shakeeb Akhter has joined MSK as its new Chief Digital Officer.

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.

MSK's Dr. Caleb Lareau was awarded a 2026 Pershing Square Sohn Cancer Prize, which is designed to empower early-career investigators to pursue bold, high-impact projects.

MSK gastrointestinal medical oncologist Eileen O'Reilly, MD (left), led a very promising early phase clinical trial of the targeted RAS therapy daraxonrasib for people facing pancreatic cancer, ...

તમારી સંપૂર્ણ સ્વરપેટી દૂર કરવાની સર્જરી પહેલાં આ વિભાગ તમને તમારી સર્જરી માટે તૈયાર થવામાં મદદ કરશે. જ્યારે તમારી સર્જરી નક્કી થાય, ત્યારે આ વાંચો ...

How Does Acupuncture Help Breast Cancer Survivors? The trial found that patients in the real and sham acupuncture groups had clinically meaningful improvements in how they perceived their cognitive ...